Gilead Sciences
GILD
#111
Rank
NZ$285.37 B
Marketcap
NZ$229.92
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.73

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.59. In 2024 the company made an earnings per share (EPS) of NZ$0.64 a decrease over its 2023 EPS that were of NZ$7.70.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.731724.09%
2024NZ$0.64-91.65%
2023NZ$7.7023.98%
2022NZ$6.21-25.86%
2021NZ$8.384850%
2020NZ$0.17-97.64%
2019NZ$7.170.9%
2018NZ$7.1118.71%
2017NZ$5.99-64.88%
2016NZ$17.06-18.45%
2015NZ$20.9255.28%
2014NZ$13.47296.02%
2013NZ$3.4017.89%
2012NZ$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.85 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.30-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.05-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.96 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.25 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$14.94 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.27-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$26.18 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.37 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA